PubMed:38154551 / 1807-1975
Annnotations
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T24 | 89-103 | Phenotype | denotes | AA amyloidosis | HP:4000041 |
T25 | 89-91 | Phenotype | denotes | AA | HP:4000041 |
T26 | 105-107 | Phenotype | denotes | AA | HP:4000041 |
T27 | 110-132 | Phenotype | denotes | membranous nephropathy | HP:0012578 |
T28 | 134-136 | Phenotype | denotes | MN | HP:0012578 |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T26 | 89-103 | Disease | denotes | AA amyloidosis | http://purl.obolibrary.org/obo/MONDO_0019439 |
T27 | 89-91 | Disease | denotes | AA | http://purl.obolibrary.org/obo/MONDO_0019439 |
T28 | 105-107 | Disease | denotes | AA | http://purl.obolibrary.org/obo/MONDO_0019439 |
T29 | 110-132 | Disease | denotes | membranous nephropathy | http://purl.obolibrary.org/obo/MONDO_0005376 |
T30 | 134-136 | Disease | denotes | MN | http://purl.obolibrary.org/obo/MONDO_0005376 |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T24 | 89-103 | Phenotype | denotes | AA amyloidosis | HP:4000041 |
T25 | 89-91 | Phenotype | denotes | AA | HP:4000041 |
T26 | 105-107 | Phenotype | denotes | AA | HP:4000041 |
T27 | 110-132 | Phenotype | denotes | membranous nephropathy | HP:0012578 |
T28 | 134-136 | Phenotype | denotes | MN | HP:0012578 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T24 | 89-103 | Disease | denotes | AA amyloidosis | MONDO:0019439 |
T25 | 89-91 | Disease | denotes | AA | MONDO:0019439 |
T26 | 105-107 | Disease | denotes | AA | MONDO:0019439 |
T27 | 110-132 | Disease | denotes | membranous nephropathy | MONDO:0005376 |
T28 | 134-136 | Disease | denotes | MN | MONDO:0005376 |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T17 | 0-168 | Sentence | denotes | Here, we performed a comparative urinary omics analysis between recently diagnosed renal AA amyloidosis (AA), membranous nephropathy (MN) patients and healthy controls. |